Reference: 214 Title: Alzheimer’s Disease as Type 3 Diabetes: Metabolic Dysfunction and Brain Glucose Summary: A 2022 MDPI review identifies Alzheimer’s disease as “Type 3 diabetes,” highlighting insulin signaling issues and neuroinflammation as key disease factors. URL: https://www.mdpi.com/1422-0067/23/5/2687